Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

CVS Corp (CVS)

CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Earnings Preview: What To Expect From CVS Health's Report

Woonsocket, Rhode Island-based CVS Health Corporation (CVS) provides health solutions in the United States. With a market cap. of $102 billion, it operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. 

CVS is expected to release its Q4 2025 results before the market opens on Wednesday, Feb. 11. Ahead of this event, analysts anticipate CVS to post an adjusted EPS of $0.99, a decline of 16.8% from $1.19 reported in the same quarter last year. However, it has surpassed the Street’s bottom-line estimates in the past four quarters.

Fundamentals

See More
  • Market Capitalization, $K 102,417,768
  • Shares Outstanding, K 1,269,432
  • Annual Sales, $ 372,809 M
  • Annual Income, $ 4,614 M
  • EBIT $ 10,641 M
  • EBITDA $ 15,238 M
  • 60-Month Beta 0.48
  • Price/Sales 0.26
  • Price/Cash Flow 8.84
  • Price/Book 1.40

Options Overview Details

View History
  • Implied Volatility 37.41% (+0.86%)
  • Historical Volatility 20.91%
  • IV Percentile 71%
  • IV Rank 42.46%
  • IV High 56.83% on 04/07/25
  • IV Low 23.07% on 08/28/25
  • Expected Move (DTE 2) 1.28 (1.60%)
  • Put/Call Vol Ratio 2.20
  • Today's Volume 10,750
  • Volume Avg (30-Day) 12,358
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 531,218
  • Open Int (30-Day) 506,160
  • Expected Range 78.34 to 80.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.99
  • Number of Estimates 10
  • High Estimate 1.03
  • Low Estimate 0.93
  • Prior Year 1.19
  • Growth Rate Est. (year over year) -16.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.02 +3.14%
on 12/22/25
81.75 -2.83%
on 01/06/26
+0.02 (+0.03%)
since 12/12/25
3-Month
74.14 +7.15%
on 12/04/25
85.15 -6.71%
on 10/29/25
-0.22 (-0.28%)
since 10/14/25
52-Week
50.63 +56.90%
on 01/16/25
85.15 -6.71%
on 10/29/25
+27.87 (+54.04%)
since 01/14/25

Most Recent Stories

More News
Earnings Preview: What To Expect From CVS Health's Report

CVS Health is scheduled to release its fourth-quarter results next month, with analysts anticipating a double-digit decline in the company’s bottom-line figure.

CVS : 79.36 (-1.64%)
XLV : 157.87 (+0.72%)
$SPX : 6,924.82 (-0.56%)
CVS Health Foundation Grants the American Diabetes Association $2.6 Million to Expand Maternal Diabetes Program Across Two Additional NYC Communities

Building on 18 months of proven success, the initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers

CVS : 79.36 (-1.64%)
1 Momentum Stock with Impressive Fundamentals and 2 Facing Challenges

1 Momentum Stock with Impressive Fundamentals and 2 Facing Challenges

CVS : 79.36 (-1.64%)
MCO : 536.02 (+0.21%)
FNB : 17.19 (+0.53%)
This ETF Is Proof That the Healthcare Rebound Is Real

Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.

CVS : 79.36 (-1.64%)
VHT : 293.48 (+0.72%)
NVO : 58.60 (-1.74%)
JNJ : 218.52 (+2.28%)
MRK : 111.01 (+2.54%)
HCA : 478.88 (-0.09%)
ABBV : 221.91 (+0.53%)
UNH : 335.10 (+0.35%)
ELV : 372.95 (+0.61%)
PFE : 25.57 (+1.67%)
TSLA : 438.97 (-1.84%)
LLY : 1,073.36 (-0.36%)
CVS Health to hold fourth quarter and full year 2025 earnings conference call

WOONSOCKET, R.I. , Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11 th , 2026, at 8:00 a.m. ET to discuss...

CVS : 79.36 (-1.64%)
CVS Health declares quarterly dividend

WOONSOCKET, R.I. , Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents)...

CVS : 79.36 (-1.64%)
2 Large-Cap Stocks Worth Your Attention and 1 We Question

2 Large-Cap Stocks Worth Your Attention and 1 We Question

CVS : 79.36 (-1.64%)
COR : 349.89 (+1.16%)
TEAM : 131.96 (-4.30%)
3 Low-Volatility Stocks We Think Twice About

3 Low-Volatility Stocks We Think Twice About

IRDM : 19.66 (+0.41%)
CVS : 79.36 (-1.64%)
FLO : 10.90 (+4.21%)
3 Cash-Producing Stocks That Fall Short

3 Cash-Producing Stocks That Fall Short

CVS : 79.36 (-1.64%)
SBGI : 15.03 (+0.20%)
HPQ : 20.75 (-1.57%)
1 Healthcare Stock to Research Further and 2 That Underwhelm

1 Healthcare Stock to Research Further and 2 That Underwhelm

CVS : 79.36 (-1.64%)
MOH : 188.90 (+4.41%)
MASI : 138.43 (+6.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed...

See More

Key Turning Points

3rd Resistance Point 82.15
2nd Resistance Point 81.60
1st Resistance Point 81.14
Last Price 79.36
1st Support Level 80.13
2nd Support Level 79.58
3rd Support Level 79.12

See More

52-Week High 85.15
Last Price 79.36
Fibonacci 61.8% 71.96
Fibonacci 50% 67.89
Fibonacci 38.2% 63.82
52-Week Low 50.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar